Global PSA test market is entering a pivotal growth phase as advancements in diagnostic accuracy, population screening initiatives, and increasing awareness of prostate cancer reshape testing practices worldwide. Valued at USD 542 million in 2024, the market is projected to reach USD 943 million by 2031, expanding at a strong CAGR of 8.4%. This growth reflects a rising emphasis on ear... https://www.24lifesciences.com/psa-test-market-8162